Conference Description
The Antibody Biology and Engineering GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
Antibodies pair an incredible diversity of functions with highly specific target binding, which enables them to play a critical role in our natural immune defense against pathogens. When this balance between specificity and potency is compromised, they can contribute to inflammatory and autoimmune diseases. Inspired by natural antibody biology, scientists have engineered countless variations of antibodies for an astounding array of therapeutic applications, transforming the lives of patients and their families.The 2026 Antibody Biology and Engineering Conference and Seminar will bring together scientists who share a fascination for the lessons we can learn from natural and engineered antibody repertoires, and a passion for applying these lessons to inform the selection, design, and development of antibody variations for innovative therapeutic applications. Attendees with academic and industrial backgrounds, from many different nationalities, and different career stages ranging from graduate students to established thought leaders, will present and discuss their latest and predominantly unpublished findings to develop ideas, forge new contacts, and initiate collaborations. They will challenge, inspire, and encourage each other to develop better treatments for common disorders such as inflammatory conditions, major infectious diseases, and cancer.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by June 11, 2025. Please check back for updates.
